Philip M. H. Marks

Most-cited papers

1. A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis.

   E. Somm, N. Bonnet, Alberto Martínez, Philip M. H. Marks +10 more

   2012Journal of Clinical Investigation62 citations Open access

   Semantic Scholar

   Save

2. Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A.

   G. Masuyer, N. Thiyagarajan, Peter L. James, Philip M. H. Marks +2 more

   2009Biochemical and Biophysical Research Communications - BBRC26 citations

   Semantic Scholar

   Save

3. Preparation of specifically activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B, and C and their applications.

   J. Sutton, Jonathan Wayne, Anthony Scott-Tucker, S. O'Brien +4 more

   2005Protein Expression and Purification23 citations

   Semantic Scholar

   Save

4. GHRH receptor-targeted botulinum neurotoxin selectively inhibits pulsatile GH secretion in male rats.

   J. Leggett, E. Harper, E. Waite, Philip M. H. Marks +2 more

   2013Endocrinology14 citations

   Semantic Scholar

   Save

5. Sputum processing methods in airway disease: Which is best?

   M. Rainer, Faizah Haider, Philip M. H. Marks, R. Mccartney +4 more

   20141 citations

   Semantic Scholar

   Save